These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 16912203)
1. Assessment of endostatin gene therapy for familial adenomatous polyposis-related desmoid tumors. Martinico SC; Jezzard S; Sturt NJ; Michils G; Tejpar S; Phillips RK; Vassaux G Cancer Res; 2006 Aug; 66(16):8233-40. PubMed ID: 16912203 [TBL] [Abstract][Full Text] [Related]
2. Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma. Brueckl WM; Ballhausen WG; Förtsch T; Günther K; Fiedler W; Gentner B; Croner R; Boxberger F; Kirchner T; Hahn EG; Hohenberger W; Wein A Dis Colon Rectum; 2005 Jun; 48(6):1275-81. PubMed ID: 15793634 [TBL] [Abstract][Full Text] [Related]
3. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms]. Friedrich A; Kullmann F Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680 [TBL] [Abstract][Full Text] [Related]
4. Cranial desmoid tumor associated with homozygous inactivation of the adenomatous polyposis coli gene in a 2-year-old girl with familial adenomatous polyposis. de Silva DC; Wright MF; Stevenson DA; Clark C; Gray ES; Holmes JD; Dean JC; Haites NE; Dunlop MG Cancer; 1996 Mar; 77(5):972-6. PubMed ID: 8608492 [TBL] [Abstract][Full Text] [Related]
5. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours. Kohler EM; Chandra SH; Behrens J; Schneikert J Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359 [TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis. Bright-Thomas RM; Agrawal A; Hargest R Br J Surg; 2002 Dec; 89(12):1563-9. PubMed ID: 12445067 [TBL] [Abstract][Full Text] [Related]
7. Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations. Speake D; Evans DG; Lalloo F; Scott NA; Hill J Br J Surg; 2007 Aug; 94(8):1009-13. PubMed ID: 17410559 [TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer and genetic alterations in the Wnt pathway. Segditsas S; Tomlinson I Oncogene; 2006 Dec; 25(57):7531-7. PubMed ID: 17143297 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive genetic and endoscopic evaluation may be necessary to distinguish sporadic versus familial adenomatous polyposis-associated abdominal desmoid tumors. Bandipalliam P; Balmana J; Syngal S Surgery; 2004 Jun; 135(6):683-9. PubMed ID: 15179376 [TBL] [Abstract][Full Text] [Related]
10. [Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register]. Kadmon M; Möslein G; Buhr HJ; Herfarth C Chirurg; 1995 Oct; 66(10):997-1005. PubMed ID: 8529453 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations. Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219 [TBL] [Abstract][Full Text] [Related]
12. Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle. Durno CA; Gallinger S J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):5-15. PubMed ID: 16819371 [TBL] [Abstract][Full Text] [Related]
13. [Clinical follow-up and treatment of patients with familial adenomatous polyposis]. Saurin JC Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B31-7. PubMed ID: 11449143 [No Abstract] [Full Text] [Related]
14. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis. Jilong Y; Jian W; Xiaoyan Z; Xiaoqiu L; Xiongzeng Z Pathology; 2007 Jun; 39(3):319-25. PubMed ID: 17558858 [TBL] [Abstract][Full Text] [Related]
15. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor). Tolg C; Poon R; Fodde R; Turley EA; Alman BA Oncogene; 2003 Oct; 22(44):6873-82. PubMed ID: 14534534 [TBL] [Abstract][Full Text] [Related]
16. [Desmoid tumors in patients with familial adenomatous polyposis]. Pikaar A; Nortier JW; Griffioen G; Vasen HF Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1355-9. PubMed ID: 12162172 [TBL] [Abstract][Full Text] [Related]
17. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180 [TBL] [Abstract][Full Text] [Related]
18. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors). Lips DJ; Barker N; Clevers H; Hennipman A Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078 [TBL] [Abstract][Full Text] [Related]
19. Does early colectomy increase desmoid risk in familial adenomatous polyposis? Durno C; Monga N; Bapat B; Berk T; Cohen Z; Gallinger S Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1190-4. PubMed ID: 17916546 [TBL] [Abstract][Full Text] [Related]